![]() |
市場調查報告書
商品編碼
1797673
組織黏合劑的全球市場:類型·用途·終端用戶·各地區 (~2035年)Global Tissue Adhesives Market Research Report by Type, by Application, by End User, and by Region Forecast till 2035 |
預計2035年,全球組織黏合劑市場規模將達到68.9億美元,預測期內的複合年增長率為9.06%。
組織黏合劑是一種專用醫用黏合劑,主要用於皮膚傷口閉合。透過與組織牢固黏合,組織黏合劑提供了一種創傷性較小的傷口閉合方法,從而加快傷口癒合速度並改善美觀效果。
仿生黏合劑、奈米技術增強黏合劑和聚合物基黏合劑的創新正在徹底改變傷口閉合。這些進步提高了黏合強度,縮短了閉合時間,並降低了感染風險,使組織黏合劑成為現代微創手術的重要組成部分。此外,凝膠和噴霧等改進的給藥系統正在加速普及,使下一代黏合劑成為全球高效、永續、以患者為中心的外科護理的基礎。
區域洞察
北美仍是最大的區域市場,佔全球收入的40%以上。心血管、骨科和重建手術病例的大量增加使得組織黏合劑成為現代外科手術的重要組成部分。預計到2024年,美國將以9.1372億美元的市場規模佔北美市場的主導地位,其次是加拿大,市場規模達1.999億美元。美國仍然是歐洲大陸最強大的市場,這主要歸功於其龐大的研發投入和對新型生物基黏合劑的快速應用。
在歐洲,組織黏合劑在專科外科手術中的應用正在穩步擴大。德國、英國和法國是主要的收入來源。預計到2024年,德國將成為歐洲最大的市場,市場規模達2.0281億美元,其次是英國,市場規模達1.529億美元,法國則達1.276億美元。歐洲醫療保健系統著重縮短住院時間和恢復時間,而組織黏合劑的優勢與這一趨勢相得益彰。
亞太市場快速成長的動力源於其所需的大量外科手術以及人們對非侵入性傷口閉合方法日益增長的認識。到2024年,中國將以1.3408億美元的市場規模領先亞太市場,其次是日本(1.1207億美元)和印度(9,885萬美元)。受醫療保健覆蓋範圍不斷擴大和外科手術數量不斷增加的推動,這些國家將主導亞太地區的需求。尤其是中國和印度市場,由於創傷病例激增、私立和公立醫院投資增加以及政府主導的促進外科耗材國產化的舉措,正在經歷快速增長。
本報告研究了全球組織黏合劑市場,提供了市場定義和概述、影響市場成長的各種因素分析、市場規模趨勢和預測、按細分市場、地區和主要國家/地區進行的細分、競爭格局以及主要公司的概況。
Global Tissue Adhesives Market Research Report by Type [Synthetic & semi-Synthetic Adhesives (Cyanoacrylates, Polyethylene Glycol, Gelatin-Formaldehyde, Others), Natural Adhesives (Fibrin, Collagen, Dextran, Chitosan, Others)], by Application [Surgery (Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Neurosurgery, Plastic & Reconstructive Surgery, Ophthalmic Surgery, Urological Surgery, Thoracic Surgery, Others), Wound Care, Burn Treatment], by End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers, Research Laboratories & Institutes), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035
The global tissue adhesives market is expected to reach USD 6.89 billion by 2035 at a CAGR of 9.06%. Tissue adhesives are medically specialized glues that are essentially beneficial for closing wounds in the skin. Moreover, by bonding to the tissue tightly and securely, they offer a less intrusion method of wound closure, thus generally leading to faster healing and better aesthetic results.
Innovation in bio-inspired, nanotechnology-enhanced, and polymer-based adhesives is transforming wound closure. These advancements improve bonding strength, cut closure times, and reduce infection risk, making tissue adhesives vital in modern minimally invasive surgeries. Enhanced delivery systems such as gels and sprays further accelerate adoption, positioning next-generation adhesives as a cornerstone of patient-centric, efficient, and sustainable surgical care worldwide.
Major Company Developments
B. Braun continues to strengthen its global footprint by emphasizing innovation, advanced technologies, and patient-centric healthcare solutions. The company invests heavily in R&D to develop next-generation products and improve existing ones, ensuring responsiveness to unmet medical needs. Its strategy revolves around four pillars-collaboration, cutting-edge integration, digital excellence, and customer alignment. In Hospital Care, the company is optimizing infusion pumps with integrated medication management systems. Aesculap focuses on expanding digital and robotic-assisted surgical solutions, while Avitum advances efficiency and connectivity in dialysis therapies. With ongoing refinement of chronic and acute treatment offerings, B. Braun is well-positioned to provide seamless, technology-driven solutions that enhance clinical efficiency, patient safety, and healthcare outcomes worldwide.
Major players in the global tissue adhesives market are Meyer Haake GmbH, Essity, Zhejiang Perfectseal, Baxter, Chemence Medical, Inc., H.B. Fuller Medical Adhesive Technologies, LLC., Becton, Dickson and Company (BD), B. Braun, Artivion, GEM SRL, Advanced Medical Solutions (AMS), and Cohera Medical, Inc.
Report Attribute Details
Market Size 2024 USD 2,649.88 Million
Market Size 2035 USD 6,892.51 Million
CAGR (2025-2035) 9.06%
Base Year 2024
Market Forecast Period 2025-2035
Historical Data 2019, 2022, 2023
By Type: Synthetic & Semi-Synthetic Adhesives - 8.30%, Natural Adhesives - 10.20%.
By Application: Surgery- 9.04%, Wound Care - 10.42%.
By End User: Hospitals and Specialty Clinics - 8.62%, Ambulatory Surgical Centers (ASCs) - 10.13%.
Regional Insights
North America is still the largest regional market by far, making up more than 40% of the total revenue share worldwide. The numerous cases of cardio-vascular, orthopedic, and reconstructive surgery have made tissue adhesives a must-have in modern surgical procedures. The U.S. dominates the North American tissue adhesives market with USD 913.72 million in 2024, while Canada follows with USD 199.90 million. The U.S. is still the most powerful country on the continent, primarily due to the large R&D investments and quick adoption of novel bio-based adhesives.
Europe demonstrates robust usage of tissue adhesives in specialized surgeries, where Germany, the UK, and France have been the major revenue centers. Germany is Europe's largest tissue adhesives market at USD 202.81 million in 2024, followed by the UK with USD 152.90 million and France with USD 127.60 million. The healthcare systems in Europe are focusing on shortened hospital stays and quicker recovery times, which is compatible with the effectiveness provided by tissue adhesives.
The drive behind the fast growth of the Asia-Pacific market is the huge volume of surgical procedures required and the increasing recognition of non-invasive wound closure methods. China tops the APAC tissue adhesives market with USD 134.08 million in 2024, followed by Japan at USD 112.07 million and India at USD 98.85 million. These countries dominate regional demand, fueled by expanding healthcare access and surgical procedures. China and India's markets are expanding rapidly due to a surge in trauma cases and rising investments in both private and public hospitals, supported by the government-backed initiatives to localize production of surgical consumables.
The Rest of the World market is growing steadily, led by Brazil's rise in cosmetic surgeries, Gulf states' investments in advanced healthcare, and gradual adoption in Africa, supported by global healthcare partnerships despite access and cost challenges.